IP Library Patent Application 13054543
Patent Application
App. No. 13/054,543

Methods, Devices, and Systems for Glycated Hemoglobin Analysis

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/054,543
Abstract

Methods, devices, and systems for measuring the concentration of glycated hemoglobin (HbA 1 c) in a blood sample are provided. A blood sample may be contacted with a lysing agent, an assay to measure total Hb, and an assay to measure HbA 1 c, which comprises donor and acceptor dyes attached to a Hb specific antibody and a HbA 1 c analog. Preferably, the emission spectrum of the donor dye overlaps with the excitation spectrum of the acceptor dye. The concentration of HbA 1 c in the sample may be correlated with an increase in donor dye and/or a decrease in acceptor dye fluorescence in the presence of HbA 1 c as compared to the donor and/or the acceptor dye fluorescence in the absence of HbA 1 c.

Claims (47)

1 . A method for determining the concentration of glycated hemoglobin (HbA1c) in a sample, comprising:

contacting the sample with a red blood cell lysing mixture;

contacting the sample with a total hemoglobin assay;

contacting the sample with a HbA1c assay including one of

a fluorescent donor dye conjugated to a HbA1c analog and a fluorescent acceptor dye attached to a Hb-specific antibody, and

a fluorescent donor dye attached to a Hb-specific antibody and a fluorescent acceptor dye attached to a HbA1c analog,

where the emission spectrum of the fluorescent donor dye overlaps with the excitation spectrum of the fluorescent acceptor dye; and

correlating the concentration of HbA1c in the sample with a change in the intensity of at least one of donor dye fluorescence and acceptor dye fluorescence.

2 . The method of claim 1 , where the total hemoglobin assay comprises:

converting hemoglobin to a metal-hemoglobin complex; and

detecting the intensity of light responsive to the metal-hemoglobin complex.

3 . The method of claim 1 , the fluorescent donor dye having an absorption maximum at an excitation wavelength from about 590 to about 660 nanometers.

4 . The method of claim 1 , the fluorescent acceptor dye having an absorption maximum at an excitation wavelength from about 630 to about 760 nanometers.

5 . The method of claim 1 , where the fluorescent donor dye is fluorescein isothiocyanate and the fluorescent acceptor dye is tetramethylrhodamine isothiocyanate.

6 . The method of claim 1 , where the HbA1c analog is any molecule that binds to the HbA1c-specific antibody with less affinity than HbA1c.

7 . The method of claim 1 , where the HbA1c analog is selected from the group consisting of glycated peptides, multiple antigen peptides, and combinations thereof.

8 . The method of claim 1 , where the fluorescence of the fluorescent donor dye and the fluorescence of the fluorescent acceptor dye are detected at a wavelength from about 450 to about 520 nanometers or greater than about 600 nanometers.

9 . The method of claim 1 , the fluorescent acceptor dye replaced with a quenching dye.

10 . The method of claim 1 , where the change in the intensity includes an increase in the intensity of the donor dye fluorescence and a decrease in the intensity of the acceptor dye fluorescence.

11 . The method of claim 1 , where the change in the intensity includes a decrease in the intensity of the donor dye fluorescence and an increase in the intensity of the acceptor dye fluorescence.

12 . A hemoglobin ratio determination system, comprising:

a vial comprising a lysing mixture;

a sensor strip,

where a total hemoglobin assay is included with the lysing mixture or the sensor strip,

where a HbA1c assay is included with the lysing mixture or the sensor strip, and where the HbA1c assay includes

a fluorescent donor dye attached to a HbA1c analog and a fluorescent acceptor dye attached to an Hb-specific antibody, or

a fluorescent donor dye attached to a Hb-specific antibody and a fluorescent acceptor dye attached to a HbA1c analog, and where

an emission spectrum of the fluorescent donor dye overlaps with an excitation spectrum of the fluorescent acceptor dye; and

an electronic measurement device including a processor, where the processor is operable to determine a ratio of HbA1c to total hemoglobin.

13 . The system of claim 12 , where the processor determines a comparison of the decrease in the acceptor dye fluorescence in the presence of HbA1c to the acceptor dye fluorescence in the absence of HbA1c.

14 . The system of claim 12 , where the processor determines a comparison of the increase in donor dye fluorescence in the presence of HbA1c to the donor dye fluorescence in the absence of HbA1c.

15 . The system of claim 13 , where the processor determines a correlation of HbA1c in the sample responsive to the comparison and the ratio of HbA1c to total hemoglobin is responsive to the correlation.

16 . The system of claim 15 , where the processor determines the total hemoglobin in the sample substantially before determining the HbA1c in the sample.

17 . The system of claim 12 , the fluorescent acceptor dye replaced with a quenching dye.

18 . A HbA1c sample concentration determination kit, comprising:

a vial including a lysing mixture, a total Hb assay, and a HbA1c assay, the HbA1c assay including one of

a fluorescent donor dye attached to a HbA1c analog and a fluorescent acceptor dye attached to an Hb-specific antibody, and

a fluorescent donor dye attached to a Hb-specific antibody and a fluorescent acceptor dye attached to a HbA1c analog; and where

an emission spectrum of the donor dye overlaps with an excitation spectrum of the acceptor dye.

19 . The kit of claim 18 , the fluorescent acceptor dye replaced with a quenching dye.

20 . A HbA1c sample concentration determination kit, comprising:

a vial including a lysing mixture and a total Hb assay, and

a sensor strip including a HbA1c assay, the HbA1c assay including one of

a fluorescent donor dye attached to a HbA1c analog and a fluorescent acceptor dye attached to an Hb-specific antibody, and

a fluorescent donor dye attached to a Hb-specific antibody and a fluorescent acceptor dye attached to a HbA1c analog; and where

an emission spectrum of the donor dye overlaps with an excitation spectrum of the acceptor dye.

21 . The kit of claim 20 , the fluorescent acceptor dye replaced with a quenching dye.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2023
From: PNC BANK, NATIONAL ASSOCIATION ,AS AGENT
To: POLYMER TECHNOLOGY SYSTEMS,INC.
Reel/Frame 062496/0384 →
SECURITY INTEREST Recorded Jun 4, 2014
From: POLYMER TECHNOLOGY SYSTEMS, INC.
To: PNC BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 033083/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2014
From: BAYER HEALTHCARE, LLC
To: PTS ACQUISITION CORPORATION
Reel/Frame 032173/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2014
From: PTS ACQUISITION CORPORATION
To: POLYMER TECHNOLOGY SYSTEMS, INC.
Reel/Frame 032173/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2011
From: CHINNAYELKA, SWETHA
To: BAYER HEALTHCARE LLC
Reel/Frame 025867/0066 →